Dehua Chang | Regenerative Medicine Research | Best Researcher Award

Published on by Best Achievements

Dr. Dehua Chang | Regenerative Medicine Research | Best Researcher Award 

University of Tokyo Hospital | Japan

Dr. Dehua Chang, M.D., Ph.D., is a highly accomplished researcher and clinician specializing in cardiovascular surgery and regenerative medicine. He currently serves as a Specially Appointed Associate Professor at the Department of Cell Therapy in Regenerative Medicine, University of Tokyo Hospital, and holds multiple visiting professorships at leading institutions, including Fudan University, Shanghai Jiao Tong University, and Zhengzhou University. With a prolific academic and professional background spanning Japan, China, Europe, and the United States, Dr. Chang has made significant contributions to stem cell therapy, tissue engineering, and cardiac regeneration. His work has been widely recognized, with 29 published documents, 838 citations, and an h-index of 15, reflecting his influential research impact in the field. He has developed several innovative patents related to cell sheet technologies and mesenchymal stem cell applications, advancing translational approaches in regenerative medicine. As a member of the Japanese Society for Regenerative Medicine and a reviewer for leading journals such as Stem Cell Research & Therapy, Regenerative Therapy, and Acta Biomaterialia, Dr. Chang contributes extensively to scientific peer review and editorial excellence. His clinical and research expertise encompasses cell-based therapies for ischemic heart disease, heart failure, osteoarthritis, and vascular disorders, with a focus on the industrialization and clinical application of stem cell sheet products. Fluent in Chinese, English, and Japanese, Dr. Chang bridges international collaboration, academic leadership, and innovation in regenerative cardiovascular medicine, positioning him as a global expert in translational medical research and clinical cell therapy.

Profile: Scopus 

Featured Publications 

Wang, Y.-H., Liu, T.-T., Guo, Y.-P., Zhu, S.-J., Liao, Z.-M., Song, J.-M., Zhu, X.-M., Liang, J.-L., Nasser, M. I., Liu, N.-B., Chang, D.-H., Zhu, P., & Yao, B.* (2025). Integrating melt electrospinning writing and microfluidics to engineer a human cardiac microenvironment for high-fidelity drug screening. Bioactive Materials.

Zhu, S., Xuan, J., Shentu, Y., Kida, K., Kobayashi, M., Wang, W., Ono, M., & Chang, D.* (2024). Effect of chitin-architected spatiotemporal three-dimensional culture microenvironments on human umbilical cord-derived mesenchymal stem cells. Bioactive Materials

Ke Li | Nanotechnology | Best Researcher Award

Published on by Best Achievements

Dr. Ke Li | Nanotechnology | Best Researcher Award 

Wuxi Ninth People’s Hospital Affiliated to Soochow University | China

Dr. Ke Li is an accomplished researcher specializing in orthopaedic surgery with a Ph.D. from Yangzhou University, holding prior degrees in Orthopaedic Surgery (M.M., China Medical University) and Clinical Medicine (B.M., Fujian University of Traditional Chinese Medicine). His research primarily focuses on constructing bio-nanomaterials that target various effector cells in the bone aging microenvironment to develop innovative anti-osteoporosis therapies. As the Principal Investigator of the Jiangsu Provincial Postgraduate Research & Practice Innovation Program, he leads a project on developing a nanozyme-based gene-editing platform for bone cell coupling and osteoporosis treatment. Dr. Li has an impressive portfolio of 23 scholarly publications, accumulating 391 citations and an h-index of 11, underscoring his scientific impact and research excellence. His notable works include pioneering studies on nitric oxide nanopumps for bone marrow regeneration (Nature Communications), cellular senescence mechanisms in skeletal diseases (Bone Research), and nanozyme-based gene editing for reversing osteoporosis (Nano Today). Additionally, his research extends to drug delivery systems, chemo-immunotherapy, and tumor microenvironment modulation, with publications in high-impact journals such as Bioactive Materials, Materials & Design, and Frontiers in Oncology. Dr. Li’s contributions significantly advance the understanding of bone aging, nanomedicine, and regenerative therapy, providing a foundation for translational applications in orthopaedics and related biomedical fields. His innovative approach to integrating nanotechnology with molecular biology continues to drive breakthroughs in therapeutic strategies for skeletal and degenerative diseases.

Profile: Scopus 

Featured Publications 

Li, K., Hu, S., Li, H., et al. (2025). Remodeling adipocytes’ lipid metabolism with a polycation loaded enzyme-active framework reverses osteoporotic bone marrow. Nature Communications.

Li, K., Hu, S., Chen, H., et al. (2025). Cellular senescence and other age-related mechanisms in skeletal diseases. Bone Research.

Guoping Liu | Veterinary Medicine | Best Researcher Award

Published on by Best Achievements

Prof. Guoping Liu | Veterinary Medicine | Best Researcher Award 

Yangtze University | China

Professor Liu Guoping is a distinguished scholar and expert in veterinary medicine with extensive contributions to animal health management and disease prevention. Currently serving as a Professor and Doctoral Supervisor at the College of Animal Science, Yangtze University, he also holds multiple leadership positions, including Director of the Black Pig Research Institute, Director of the Hubei Gongfu Pig Breeding Technology Innovation Center, and Deputy Director of the Environmental Control Innovation Platform under the Provincial Collaborative Innovation Center for Healthy Pig Breeding. His research focuses on early warning, prevention, and eradication of major swine diseases such as African swine fever, PRRS, pseudorabies, and parvovirus. He has pioneered the development of microbial-driven technologies for selenium-rich pig breeding and promoted eco-friendly agricultural models integrating “two farms and one factory.” Professor Liu has applied for invention patents, forming a robust technology protection network. His team has achieved remarkable results in technology and established strategic partnerships with prominent enterprises such as Hubei Gongfu Animal Husbandry Co., Sinopharm Group Animal Health Co., and Jiahe Agricultural and Animal Husbandry Group. A prolific researcher with 25 published documents, 280 citations, and an h-index of 11, he has been recognized with multiple honors, including the Third Prize of the Hubei Provincial Science and Technology Progress Award. His pioneering work has been widely featured in People’s Daily, China Education Daily, and Southern Rural News, highlighting his impactful role in promoting rural revitalization and global cooperation in animal health.

Profile: Scopus 

Featured Publications 

Yi, W., Liu, G., Wang, M., Wang, J., Chen, D., & Shen, J. (2025). Increased nitrogen deposition and airborne particulate matter pollution in the vicinity of intensive animal farms caused by ammonia emissions. Agriculture, Ecosystems & Environment

Zhang, S., Zhao, C., Liu, G., Guo, L., Zhang, R., Yan, J., He, J., & Guo, C. (2025). Monitoring of pathogens carried by imported flies and cockroaches at Shenzhen ports. Tropical Medicine and Infectious Disease.

Rashid Munir | Pharmaceutical Technology | Best Researcher Award

Published on by Best Achievements

Mr. Rashid Munir | Pharmaceutical Technology | Best Researcher Award 

Marburg University | Germany

Dr. Rashid Munir is an enthusiastic PhD researcher specializing in multifunctional nanocarriers for the co-delivery of drugs and genes, currently pursuing his doctoral research at Philipps University of Marburg, Germany. His research focuses on developing lipid-based nanocarriers, including liposomes and lipopolyplexes, for enhanced gene therapy and drug delivery in tumor models. He has extensive expertise in nanomedicine formulation, gene and drug delivery systems, and advanced physico-chemical characterization methods such as MTT, pGFP transfection, DLS, and confocal laser scanning microscopy. His technical proficiency extends to polymeric nanoparticles, dual drug–gene delivery systems, and analytical software such as ImageJ, GraphPad Prism, Origin, and Zetasizer Nano. Dr. Munir’s academic foundation includes an MPhil in Pharmaceutics from Quaid-i-Azam University, Islamabad, and a Doctor of Pharmacy (Pharm-D) from the University of Peshawar. He has published two peer-reviewed scientific articles and authored a master’s thesis on targeted drug delivery for rheumatoid arthritis. His research contributions, cited 48 times across 48 documents, demonstrate a growing impact in the fields of nanomedicine and targeted therapeutics, with an h-index of 1. Beyond research, he has served as a Pharmacist at Tianshi International and a Research Assistant at Quaid-i-Azam University, where he gained valuable experience in formulation design, in vitro assays, and academic mentoring. His commitment to innovation and translational research continues to drive advancements in drug delivery, gene therapy, and cancer nanotechnology

Profile: Scopus 

Featured Publications 

Schöne, L., Klein, S. C., Schorr, D., Preis, E., Engelhardt, K., Diemer, S., Munir, R., Schlüter, S., Schäfer, J., & Bakowsky, U. (2025). Optimizing the antimicrobial photodynamic efficacy of curcumin liposomes to treat pulmonary infections caused by gram-positive bacteria. European Journal of Pharmaceutical Sciences.

Anam Khan | Pharmaceutics | Best Researcher Award

Published on by Best Achievements

Ms. Anam Khan | Pharmaceutics | Best Researcher Award 

Marburg University | Germany

Dr. Anam Sajjad Khan is an enthusiastic Ph.D. researcher at the Philipps University of Marburg, Germany, specializing in nanocarriers for oral and dermal drug delivery. Her research expertise encompasses physicochemical characterization, formulation optimization, and ex-vivo study models for enhancing drug bioavailability and therapeutic performance. With a strong academic foundation, she holds a Master of Philosophy in Pharmaceutics and a Doctor of Pharmacy degree from Quaid-i-Azam University, Islamabad, where she developed a keen interest in nanomedicine and cosmetology. Her doctoral work is focused on developing innovative nanocarrier systems for targeted and controlled drug delivery applications. Dr. Khan has contributed to the scientific community through one published document. Alongside her academic pursuits, she has gained professional experience as a Drug Inspector with the Provincial Health Department of Khyber Pakhtunkhwa, ensuring regulatory compliance within the pharmaceutical sector, and as a Lecturer at Abasyn University Islamabad, where she taught core pharmaceutical subjects and participated in academic committees. Her dedication to research and education has been recognized through multiple awards and honors, including a prestigious DAAD research grant for doctoral studies in Germany and first position in a poster presentation at an international conference. Multilingual in English, German, Urdu, and Pashto, Dr. Khan continues to advance her research in nanotechnology-based drug delivery systems, contributing to the evolving landscape of pharmaceutical sciences and nanomedicine.

Profile: Scopus 

Featured Publications 

Roscettia, L., Keck, C. M., Chaiprateep, E., Sehra, T., Alkhaldi, M., Khan, A. S., Sengupta, S., Busch, L., Kleuser, B., Meinke, M. C., & Klein, A. L. (2025). Enhanced follicular penetration of antiseptics using nanocrystals – investigated via novel hair follicle content removal method. International Journal of Pharmaceutics, 685, Article 122435

Hina Singh | Neuroscience | Best Researcher Award

Published on by Best Achievements

Dr. Hina Singh | Neuroscience | Best Researcher Award 

University of California, Riverside | United States

Dr. Hina Singh, Ph.D., currently serves as an Assistant Project Scientist in the Division of Biomedical Sciences at the School of Medicine, University of California, Riverside, USA. Her research focuses on neuroHIV, neuroimmunology, and nanobiotechnology, with particular expertise in investigating the role of interferon signaling in HIV-associated neurocognitive disorders and methamphetamine-induced neurotoxicity. She possesses extensive experience in neuronal and microglial cell culture, molecular biology, and advanced microscopy techniques, alongside proficiency in nanoparticle synthesis and biosensor development. Dr. Singh’s scholarly contributions are reflected in 55 peer-reviewed publications, accumulating over 2,190 citations and an impressive h-index of 23, highlighting her significant impact in biomedical and nanoscience research. Her scientific journey spans diverse areas, including superparamagnetic iron oxide nanoparticles, gold nanoparticle-based biosensors, and the synthesis of biocompatible nanomaterials for therapeutic applications. She has also been actively involved in mentoring students and collaborating on interdisciplinary research projects bridging neurobiology and nanotechnology. A recipient of multiple international honors such as the Early Career Investigator Travel Award and President’s Scholarship, Dr. Singh continues to advance translational research aimed at understanding molecular mechanisms underlying neuroinflammation, viral neuropathogenesis, and neuroprotective therapeutic strategies.

Profile: Scopus | Orcid 

Featured Publications 

Singh, H., et al. (2025). Medical importance and pharmacokinetics of gold nanoparticles in the human body. Molecular Cancer.

Singh, H., et al. (2025). EphB2-mediated ephrin-B reverse signaling on microglia drives an anti-viral, but inflammatory and neurotoxic response associated with HIV. Journal of Neuroinflammation.

Singh, H., et al. (2025). Advanced nanomaterials for cancer therapy: Gold, silver, and iron oxide nanoparticles in oncological applications.

Singh, H., et al. (2025). Advances in precision oncology using patient-derived organoids and functional biomaterials.

Singh, H., et al. (2024). Interferon-β deficiency alters brain response to chronic HIV-1 envelope protein exposure in a transgenic model of NeuroHIV. Brain, Behavior, and Immunity.

Lateef Busari | Malaria | Best Researcher Award

Published on by Best Achievements

Dr. Lateef Busari | Malaria | Best Researcher Award 

Fountain University | Nigeria

Dr. Lateef Oluwatoyin Busari is an accomplished researcher and lecturer specializing in parasitology, vector biology, and infectious disease epidemiology. He currently serves as a Lecturer and Research Scientist at Fountain University, Osogbo, and the Molecular Epidemiology and Vector Biology (MOVEB) Laboratory, Osun State University, Nigeria. His research focuses on the biology, transmission, and control of vector-borne diseases, particularly malaria and onchocerciasis, contributing significantly to public health interventions. Dr. Busari has served as a reviewer for several reputable international journals, including PLoS Neglected Tropical Diseases, Malaria Journal, Parasites and Vectors, BMC Research Notes, and Journal of Pure and Applied Microbiology, reflecting his active engagement in advancing scientific research. He has collaborated on major national and international research projects funded by organizations such as the Bill and Melinda Gates Foundation, Sight Savers Nigeria, and The End Fund. His scholarly contributions have earned measurable impact, with 12 citations, 4 published documents, and an h-index of 3, underscoring his growing influence in the field of parasitology and vector research. Through his academic and field-based expertise, Dr. Busari continues to enhance understanding of disease vectors and promote innovative approaches for vector control and public health improvement.

Profile: Scopus 

Featured Publications 

Busari, L. O., et al. (2025). Modelling species distribution of Anopheles gambiae s.l. in Osun State using random forest modeling approach. Scientific Reports. (Advance online publication).

Charlotte von Horn | Transplantation | Best Researcher Award

Published on by Best Achievements

Dr. Charlotte von Horn | Transplantation | Best Researcher Award 

University Hospital Essen | Germany

Dr. Charlotte von Horn, a lecturer (PD Dr) at the Department of Surgical Research, University Hospital Essen, Germany, is a distinguished researcher in the field of organ perfusion and preservation, with a particular focus on kidneys and livers. Her work bridges basic and translational research, emphasizing organ viability testing, ischemia-reperfusion injury, and the clinical application of advanced preservation strategies. She has authored 27 scientific documents and holds an h-index of 12, with 383 citations across 242 referenced documents, reflecting the substantial impact of her contributions to transplant research. Dr. von Horn has successfully completed or is engaged in 21 research projects and three consultancy or industry collaborations, demonstrating her strong connection between academia and clinical practice. Her most notable scientific achievement is the invention and development of the controlled oxygenated rewarming technique, which significantly minimizes tissue damage following cold preservation and improves post-transplant graft function. Additionally, her contributions to organ viability testing, including the identification of biomarkers and functional tests, have been instrumental in supporting surgical decisions for organ acceptance. Through her collaborative efforts with leading centers in Hannover, Munich, and Berlin, Dr. von Horn continues to advance innovative strategies that expand the available pool of donor organs and enhance transplantation outcomes.

Profile: Scopus | Orcid 

Featured Publications 

von Horn, C. (2024). End-ischemic pharmacological cocktail treatment to mitigate rewarming/reperfusion injury. Cryobiology.

von Horn, C. (2024). Role of perfusion medium in rewarming machine perfusion from hypo- to normothermia. Artificial Organs.

Pouria Mazinani | Biomechanics | Young Scientist Award

Published on by Best Achievements

Dr. Pouria Mazinani | Biomechanics | Young Scientist Award 

University of Catania | Iran

Dr. Pouria Mazinani is a highly skilled Project Manager and researcher with a multidisciplinary background in Mechanical and Civil Engineering. He holds multiple advanced degrees, including a Ph.D. in Civil Engineering from the University of Catania and dual MSc degrees in Civil and Mechanical Engineering. His research and technical expertise span biomechanics, structural analysis, computational modeling, and fluid mechanics, with a particular focus on the simulation of corneal Young’s modulus using ABAQUS, Python, and Elastography. Dr. Mazinani has demonstrated strong analytical and leadership abilities through his roles at IDRA Quality Inspection Company and IQI Group, where he managed engineering projects, conducted mechanical equipment inspections, and ensured compliance with international quality standards. His academic contributions include five research documents, accumulating 13 citations and an h-index of 2, reflecting his growing impact in the engineering research community. Proficient in a wide range of software tools such as ANSYS, COMSOL, MATLAB, and AutoCAD, he also holds numerous professional certifications in quality management systems, data science, gas turbines, and project management. Dr. Mazinani’s combination of technical expertise, project management acumen, and research excellence underscores his commitment to advancing innovative engineering solutions.

Profile: Scopus 

Featured Publications 

Mazinani, P. (2025). Evaluating corneal biomechanics using intraocular pressure methods and finite element modeling: Parameters study and parametric optimization. Zeitschrift für Angewandte Mathematik und Physik.

Michel Muteaya Manika | Infectiology | Best Researcher Award

Published on by Best Achievements

Dr. Michel Muteaya Manika | Infectiology | Best Researcher Award

University of Lubumbashi | Congo, Democratic Republic of the

Dr. Michel Manika Muteya is a highly accomplished physician and anesthesiologist-intensivist from the Democratic Republic of Congo, with extensive expertise in general medicine, anesthesia, intensive care, emergency medicine, disaster medicine, pain management, and transfusion medicine. He has served as Head of the Anaesthesiology and Intensive Care Medicine Department at the University Teaching Hospital of Lubumbashi. His distinguished career spans clinical practice, teaching, and research, including his long-standing role as a Research Assistant in the Department of Anesthesia-Resuscitation at the University of Lubumbashi. Dr. Muteya holds multiple advanced qualifications, including a Doctor of Medicine, a Diploma of Specialist in Anaesthesia and Intensive Care Medicine, a Diploma of Specialized Studies in Transfusion Medicine, and a Degree in Law. His professional experience also includes international training at Brugmann Hospital in Brussels and active participation in humanitarian surgical missions. A prolific researcher, Dr. Muteya has published 7 documents, which have received 67 citations across 67 different publications, reflecting an h-index of 3. His scholarly and medical contributions have significantly advanced anesthesiology and critical care in the Congolese healthcare system.

Profile: Scopus | Orcid

Featured Publications 

Ngama Kakisingi, C., Cilubula Mwelwa, G., Kapend Matanda, S., Muteya Manika, M., Kabulo Kapya, H., Nzaji Kabamba, M., Kiyana Muyumba, E., Mulumba Mwamba, C., Nani-Tuma Situakibanza, H., & Tanon, A. (2025, February 11). Service availability and readiness of tuberculosis units’ clinics to manage diabetes mellitus in Lubumbashi, Democratic Republic of the Congo. BMC Health Services Research, 25, Article 12368.